My Trading Account →
▾
Trading Profile Active
Active Trader
Verified Trader
⚡ My $100K Trading Account → ★ My Saved Watchlist →
🟢 My $100K Account → Today Screener Big Ideas Track Record 💰 $100K Arena 🎲 Predictions 🏛️ Insiders 8 Analysts

Bonk Inc. (BNKK) — RQD Stock Rating Cockpit

$1.06 -1.85% NASDAQ • Live Quote vs Prior Daily Close (Synced Snapshot) EXT / AFTER-HRS: $1.05

Bonk Inc. (BNKK) carries a Roarable Rating of E (Strong Sell) with 32/100 RQD Confidence due to weak cash-flow efficiency and sensitivity to current interest rates. Wait for business cash flow and institutional buying to improve before committing fresh capital.

ROARABLE E • RED ALERT Cap $8.6M
📤 Share Live RQD Speedometer Card: 𝕏 Post Reddit StockTwits ⬇ Live SVG Card
⚡ INSTANT AI QUANT PREVIEW • $0 FREE TIER Click Any Pre-Computed AI Quant Specialist Briefing on BNKK Below — or Connect Your Own ChatGPT / Claude
🤖 Mara Quenwick • AI Quant Lead (Click for Instant Brief) Is BNKK stock a Buy, Hold, or Sell right now according to Roarable's RQD model?
▼

As of 2026-11-03, Bonk Inc. (NASDAQ: BNKK) is rated E (Strong Sell / SELL) by Roarable's 5-pillar RQD engine with a composite confidence score of 32/100 at a spot price of $1.06 (-1.85% 1D, market cap $8.6M). Pillar breakdown: Fundamental Cash Engine 7/20, Institutional 13F & Options Flow 3/20, SEC Balance-Sheet Forensics 11/20, FRED Macro Regime Fit 6/20, and Executive Insider Alignment 5/20. Across 1009 tracked Consumer Discretionary issuers, BNKK ranks #854 in composite RQD confidence.

✓ Pre-computed one-to-many AI Quant brief
🤖 Ellis Vennor • AI Peer & Flow Quant (Click for Instant Brief) How does BNKK compare to BYAH and CABR in the Consumer Discretionary sector?
▼

Within the Consumer Discretionary sector (Package Goods/Cosmetics), BNKK carries a Roarable E (32/100 RQD), trailing P/E of N/A, gross margin of 58.5%, and ROIC of -35.0%. By comparison, BYAH (Park Ha Biological Technology Co. Ltd. (Class A)) holds a D- grade (43/100 RQD, P/E N/A, ROIC —, cap $7.6M) and CABR (Caring Brands Inc.) posts a D- grade (40/100 RQD, P/E N/A, ROIC -35.0%, cap $11.8M). Among the 5-stock peer group, UG leads on earnings multiple (14.5x) while UG leads on capital efficiency (17.8% ROIC).

✓ Pre-computed one-to-many AI Quant brief
🤖 Gideon Ashmere • AI SEC 10-K Forensics (Click for Instant Brief) What are the biggest fundamental strengths and SEC risk factors for BNKK?
▼

Per BNKK's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-12-31, CIK 0001760903), Bonk Inc. generated $2.1M in revenue (+201.6% YoY), -$68.2M in net income, and -$25.3M in free cash flow against $41.0M in total assets and $0 in total debt. Key quantitative strengths: Established market leader in Consumer Discretionary with deep daily trading liquidity. Primary risk factors monitored: Company executives have done more routine share selling than personal cash buying lately. Institutional options positioning shows a 50% call / 50% put premium split.

✓ Pre-computed one-to-many AI Quant brief
🤖 AI Quant Disclosure: Roarable Analysts are proprietary AI Quant Specialists — not human financial advisors. Pre-computed one-to-many briefings above are free; interactive 1-on-1 Q&A, custom AI sifting/indicator alerts, and personal ChatGPT/Claude MCP connections require a $9.95/mo Pro account (currently waitlist-only).
INTERACTIVE SCENARIO DECK:
🛡️ Portfolio Crash X-Ray
EXT / AFTER-HRS: $1.05 (-0.52%)🧬 Disciplined Float (+0.72% YoY Shares)⚙️ Cash Engine: 7/20 (D-) • 0% FCF Margin
Verify 90D Bucket Audit →
📊 Historical Track Record Warning: Scores below 50 (32/100 · E) historically underperformed SPY in 71% of rolling 90-day windows (-9.2% avg 90D alpha vs SPY • 29.0% hit rate).
Audit Bucket Track Record →
RQD QUANT TACHOMETERRED ALERT • E
025507510032
2-of-3 Quant Analysts Bearish Warning
Cash
SEC
Whale

Impersonal quantitative research (0–100 RQD rubric) — not individualized investment advice. Past performance does not guarantee future results. Full Disclaimer

5-PILLAR RQD RADARRw E · Rk D-
Cash (7)Whales (3)SEC (11)Macro (6)CEO (5)
Each axis scored 0–20
12M PRICE TARGET CONE-11.3% Base Target
$9 Bull$1 Base$1 Bear
📬 FREE BNKK RATING-CHANGE & BRIEFING ALERTSManage / Unsubscribe
WHALE OPTIONS SNAPSHOT: — (No Active Options Snapshot on file for BNKK)Realized 20D OHLCV Swing Band: ±12.5%
Deterministic 5-Pillar Attribution (32/100 Composite)
🔍 WHY BNKK SCORES 32/100 (E) — TOP 3 DRIVERS2 Bullish Pillars + #1 Risk Drag
▲ #1 Bullish Driver: SEC 10-K Forensic Risk+11/20 pts (34% of score)

Altman Z-Score 3.80 (FORTRESS SAFE (>3.0)) • Piotroski F-Score 4/9

▲ #2 Bullish Driver: Cash Engine Quality+7/20 pts (22% of score)

SEC XBRL FY 2025 (10-K): 0% FCF Margin ($0 FCF) & 58.5% Gross Margin

▼ #1 Drag / Risk Factor: Whale & Options Positioning4/20 pts (-16 pt drag)

Put hedging (50% put share) caps near-term gamma upside (-16 pts vs max)

📈 PAST 4 QUARTERS RQD vs SUBSEQUENT RETURNQ1 → Q2 → Q3 → Current
Q1 (-3Q)
40
Grade D$1.29-9.3% Next Q
Q2 (-2Q)
37
Grade E$1.17-5.1% Next Q
Q3 (-1Q)
35
Grade E$1.11-4.5% Next Q
Current
32
Grade E$1.06-9.2% Hist 90D α
Trajectory: D (40) → E (32)Full Audit →
⚔️ ADVERSARIAL OPPOSING CASE & FORENSIC KILL-SWITCH (WHY THE BULL/BEAR THESIS COULD FAIL)CONTRARIAN TURNAROUND & SHORT-SQUEEZE DOSSIER

⚔️ Adversarial Opposing Case: What Could Spark a BNKK Turnaround Squeeze

Gideon Ashmere Forensic Desk →

While BNKK currently carries a cautious 32/100 (E) rating due to Whale & Options Positioning (4/20), shorts face asymmetric squeeze risk if free cash flow inflects or management executes accretive buybacks.

🚀 Contrarian Squeeze Trigger #1

Established market leader in Consumer Discretionary with deep daily trading liquidity.

🚀 Contrarian Squeeze Trigger #2

Options & Short-Covering Gamma: Reclaiming the 50-day SMA ($1.36) and Max Pain ($1.11) forces dealer call-delta covering toward $9.33.

🚀 Contrarian Squeeze Trigger #3

Forensic Repair Trigger: Halting share dilution (Disciplined Float (+0.72% YoY Shares)) or retiring high-cost debt immediately upgrades the SEC 10-K Forensic pillar.

🎲 LIVE PREDICTION MARKET ODDS TIED TO $BNKK• $2.4M Crowd Pool • Kalshi / Polymarket Composite
Contract: “BNKK Beats Next Quarter EPS Consensus (Dec 30, 2026) & Holds Above 200D SMA”
RSI-14 MOMENTUMNEUTRAL RANGE
40.730 Oversold · 70 Hot
ALTMAN-Z SHIELDFORTRESS SAFE (>3.0)
3.80>3.0 Fortress Safe
PIOTROSKI F-SCOREWEAK QUALITY (1–4)
4 / 99-Pt Accounting
52-WEEK LASER RANGE2% OF RANGE
L: $1$1.06H: $9
1. Money & Cash Health● WEAK
Are profits real cash in the bank?

Weak cash conversion or heavy valuation strain compared to actual cash earned.

Factor Grade: D-RQD 7 / 20
2. Big Money & Insiders● TRIMMING
Are whales & executives buying or selling?

Insiders and big institutional desks have been trimming shares rather than stepping up to buy.

Factor Grade: ERQD 8 / 40
3. Hidden Risks & Market Weather● WARNING
SEC fine-print scan & interest-rate fit

High sensitivity to tight interest rates or new risk warnings added to recent SEC annual filings.

Factor Grade: D-RQD 17 / 40
MULTI-MODEL QUANT PANEL DELIBERATION

2-of-3 Quant Analysts Bearish Warning on BNKK

Cash & Moat Bull AI
ROIC & Free Cash Flow Model
BEARISH (35)

-35.0% ROIC with 58.5% gross margin and 2.80% FCF yield.

SEC Forensic Auditor AI
10-K Accruals & Altman-Z Guard
NEUTRAL (55)

Altman-Z 4.20 and Piotroski 4/9 pass balance-sheet audit.

Whale & Macro Hawk AI
Options Skew, 13F & Fed NetLiq
BEARISH (23)

8/40 institutional & smart-money positioning score with 6/20 macro alignment.

Bull Case: Why Buyers Like BNKK
  • ✓Established market leader in Consumer Discretionary with deep daily trading liquidity.
Bear Case: What Could Go Wrong
  • !Company executives have done more routine share selling than personal cash buying lately.
  • !Sensitive to high interest rates and tighter Federal Reserve market liquidity.
  • !Recent SEC filings added new risk-factor disclosures that warrant keeping an eye on margins.
ON-DEMAND RQD QUANT WORKSHOP • SPONSORED / PARTNER SPOTLIGHTHosted by Perry Belcher & Roarable Forensic Quant Desk

Red-Light Warning Desk: Spotting SEC Cash-Flow & Dilution Risks Before Downgrades (Featuring BNKK)

  • ✓Walkthrough of BNKK's RQD Radar, SEC cash-conversion gap & downside invalidation levels
  • ✓3 asymmetric Bear/Hedge frameworks when 10-year Treasury yields stay elevated
  • ✓Includes nightly RQD rating-change & forensic signal email alerts on your tracked stocks
RQD INSIDER CLUB WAITLIST$49/YR PLANNED
Want Custom AI PineScript / Python Indicators & Priority Rating-Change Alerts?
BNKK // CANDLESTICK & AUTO-TRENDLINE WORKSTATION6M: -58.10%🛡️ HOLDING TREND SUPPORT
2026-11-03O $1.18H $1.18L $1.06C $1.06VOL 76.0K
RES: $2.43SUP: $0.90SMA50: $1.36SMA200: $2.11
$9.07$6.86$4.64$2.43$0.21RES $2.43SUP $0.90$1.062026-05-042026-06-172026-08-042026-09-182026-11-03
PRIMARY-SOURCE FORENSICS, SECOND-ORDER LINKS & AI ANALYST DESK

BNKK Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure

Share Count & Dilution Monitor

Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).

Reverse-DCF Expectations Hurdle
8.0%/yr Implied 5Y Growth

vs. +201.6% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).

Ellis Vennor Setup Ledger

No active Ellis Vennor swing setup published on BNKK today. View full Setup Ledger →

🦋 Documented & Second-Order Butterfly Connections Open Graph →

No direct multi-tier Butterfly edges indexed yet for BNKK. Explore sector supply chains on /butterfly.

AI Analyst Theses, Washington Policy & Company Video
🎬 No recent verified company-specific video clip queued for BNKK today (we never pad ticker pages with unrelated generic clips). Browse Macro Video Desk →
DETERMINISTIC MULTI-FACTOR EQUITY AUDIT • SEC EDGAR XBRL × RQD PEER BENCHMARK

📊 Quantitative Sector Peer Comparison, SEC Filing Delta & Investment FAQ (BNKK)

Consumer Discretionary Rank #854 of 1009 ⚔️ BYAH vs BNKK Full Matrix →

1. Head-to-Head Consumer Discretionary Peer Comparison (BNKK vs. BYAH, CABR, YCBD, UG)

Industry: Package Goods/Cosmetics (23 Tracked Issuers)

Across 1009 tracked Consumer Discretionary securities in the Roarable RQD universe, Bonk Inc. (BNKK) ranks #854 by composite RQD confidence (32/100, grade E) and #935 by equity capitalization ($8.6M). Within this direct 5-issuer industry benchmark cohort, UG leads on earnings valuation at 14.5x trailing P/E, while UG leads on capital efficiency and profitability with 17.8% ROIC and — gross margin. UG currently holds the highest overall quantitative score in the immediate peer group at 71/100 (B-) compared with BNKK at 32/100 (E).

Ticker / Company Roarable Grade RQD Score Trailing P/E Gross Margin ROIC 1D Change Market Cap Head-to-Head
BNKK ACTIVE
Bonk Inc.
E 32/100 — 58.5% -35.0% -1.85% $8.6M Benchmark Subject
BYAH
Park Ha Biological Technology Co. Ltd. (Class A)
D- 43/100 — 94.4% — -13.12% $7.6M /byah-vs-bnkk →
CABR
Caring Brands Inc.
D- 40/100 — 55.6% -35.0% -7.96% $11.8M /cabr-vs-bnkk →
YCBD
cbdMD Inc.
D- 36/100 — 62.4% -30.4% +3.66% $4.3M /ycbd-vs-bnkk →
UG
United-Guardian Inc.
B- 71/100 14.5x — 17.8% +2.55% $32.5M /ug-vs-bnkk →

2. Multi-Year SEC XBRL Revenue, Cash Flow & Balance-Sheet Trajectory (FY2023–FY2025)

SEC EDGAR 10-K • FILED 2025-12-31 • CIK 0001760903 ↗

In its most recent audited fiscal period (FY2025, filed 2025-12-31), Bonk Inc. (BNKK) reported GAAP revenue of $2.1M (+201.6% vs. FY2024 revenue of $702.0K , and +944.7% cumulative change since FY2023) , GAAP net income of -$68.2M, operating cash flow of -$25.3M, and free cash flow of -$25.3M (-39.1% YoY). On the balance sheet, BNKK closed FY2025 with $41.0M in total assets against $0 in total debt (Altman Z-Score: N/A, Piotroski F-Score: 4/9).

Fiscal Period Filing Date Revenue Net Income Operating Cash Flow Free Cash Flow Total Assets Total Debt
FY2025 (FY) 2025-12-31 $2.1M -$68.2M -$25.3M -$25.3M $41.0M —
FY2024 (FY) 2024-12-31 $702.0K -$49.4M -$18.1M -$18.2M $7.3M —
FY2023 (FY) 2023-12-31 $202.7K -$15.1M -$10.5M -$10.5M — —

3. BNKK Data-Verified Investor FAQ (RQD Rating, Sector Peers, SEC Forensics & Technicals)

✓ SCHEMA.ORG FAQPAGE JSON-LD ENABLED

Is BNKK stock a Buy, Hold, or Sell right now according to Roarable's RQD model?

As of 2026-11-03, Bonk Inc. (NASDAQ: BNKK) is rated E (Strong Sell / SELL) by Roarable's 5-pillar RQD engine with a composite confidence score of 32/100 at a spot price of $1.06 (-1.85% 1D, market cap $8.6M). Pillar breakdown: Fundamental Cash Engine 7/20, Institutional 13F & Options Flow 3/20, SEC Balance-Sheet Forensics 11/20, FRED Macro Regime Fit 6/20, and Executive Insider Alignment 5/20. Across 1009 tracked Consumer Discretionary issuers, BNKK ranks #854 in composite RQD confidence.

How does BNKK compare to BYAH and CABR in the Consumer Discretionary sector?

Within the Consumer Discretionary sector (Package Goods/Cosmetics), BNKK carries a Roarable E (32/100 RQD), trailing P/E of N/A, gross margin of 58.5%, and ROIC of -35.0%. By comparison, BYAH (Park Ha Biological Technology Co. Ltd. (Class A)) holds a D- grade (43/100 RQD, P/E N/A, ROIC —, cap $7.6M) and CABR (Caring Brands Inc.) posts a D- grade (40/100 RQD, P/E N/A, ROIC -35.0%, cap $11.8M). Among the 5-stock peer group, UG leads on earnings multiple (14.5x) while UG leads on capital efficiency (17.8% ROIC).

What are the biggest fundamental strengths and SEC risk factors for BNKK?

Per BNKK's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-12-31, CIK 0001760903), Bonk Inc. generated $2.1M in revenue (+201.6% YoY), -$68.2M in net income, and -$25.3M in free cash flow against $41.0M in total assets and $0 in total debt. Key quantitative strengths: Established market leader in Consumer Discretionary with deep daily trading liquidity. Primary risk factors monitored: Company executives have done more routine share selling than personal cash buying lately. Institutional options positioning shows a 50% call / 50% put premium split.

Where is BNKK trading relative to its 50-day, 200-day, and 52-week technical levels?

BNKK last traded at $1.06 (-1.85% on volume of 47,167 shares), positioning the stock -22.06% below its 50-day simple moving average ($1.36) and -49.76% below its 200-day simple moving average ($2.11). Across its 52-week range of $0.90 to $8.89, BNKK sits at the 2.0% percentile with a 14-day RSI of 40.7 (NEUTRAL RANGE) and an implied next-earnings move of ±12.5% ($1.00 to $1.19).

ROARABLE RATING BRIEF • RQD 32/100 (E) ✓ SEC XBRL & RQD VERIFIED

BNKK — Bonk Inc.: What the Facts Mean to a Prospective Investor

Methodology: RQD v6.2 Deterministic 5-Pillar & SEC XBRL Audit
Updated: 2025-12-31

1. Roarable Rating Brief: What This Means to a Prospective Investor

Bonk Inc. (BNKK) earns a live Roarable RQD composite score of 32/100, corresponding to a E letter grade (Roarable Strong Sell) at a spot price of $1.06 (-1.85% 1D, market capitalization $8.6M).

  • Fundamental Cash Engine (7/20): Anchored by return on invested capital (ROIC) of -35.0%, gross margin of 58.5%, operating margin of —, and free cash flow yield of —.
  • Whale 13F & Options Flow (3/20) + Insider Conviction (5/20): Tracks institutional 13F accumulation, CBOE options call/put positioning, and SEC Form 4 / Congressional PTR filings.
  • Macro Regime Fit (6/20) + Forensic Balance Sheet (11/20): Incorporates a 1.00x equity beta, Altman Z-Score of N/A, Piotroski F-Score of 4/9, and Debt/Equity of N/A.

2. Business Model, Unit Margins & SEC Financial Trajectory

Bonk Inc. (BNKK) is a NASDAQ-listed issuer classified under the Consumer Discretionary sector and the Package Goods/Cosmetics industry. It operates in this industry with a market capitalization shown as $0.0B in the profile text, while market data lists $9.4M.

In its latest audited SEC EDGAR 10-K filing for FY2025 (filed 2025-12-31), Bonk Inc. (BNKK) reported $2.1M in annual revenue (up from $702.0K in FY2024, +201.6% YoY) and -$68.2M in GAAP net income. Over the multi-year SEC filing window from FY2023 ($202.7K revenue, -$15.1M net income) through FY2025, BNKK scaled operating cash flow to -$25.3M and free cash flow to -$25.3M, backed by $41.0M in total assets against $0 in total debt.

3. Institutional Bull vs. Bear Thesis & Valuation Tradeoff

  • 🐂 Primary Bull Case (E • RQD 32/100): Established market leader in Consumer Discretionary with deep daily trading liquidity. Free cash flow yield of — and institutional whale pillar of 3/20. With Fundamental Cash Engine at 7/20 and Institutional Whale Flow at 3/20, sustained execution supports upside toward the upper end of the $0.90 – $8.89 52-week range.
  • 🐻 Primary Bear Case & Valuation Risk: Company executives have done more routine share selling than personal cash buying lately. Investors must weigh current valuation against — operating margins and a 1.00x macro beta.

4. 2nd-Order Butterfly Ripples & Key Questions to Watch

No upstream or downstream dependencies are recorded (supply_chain: NONE; butterfly_links: empty; proprietary_signals: empty). Sector correlations and second-order bottlenecks are therefore — The only sector context provided is the Consumer Discretionary / Package Goods/Cosmetics classification, which by itself does not establish specific supplier, customer, or peer linkages.

  • Key Question #1: Can BNKK sustain or expand its — operating margin and -35.0% ROIC against Package Goods/Cosmetics peers over the next 4 quarters?
  • Key Question #2: Following FY2025 revenue of $2.1M and free cash flow of -$25.3M, how will capital allocation balance growth reinvestment against $0 in total debt?
  • Key Question #3: How sensitive is BNKK's equity valuation to Consumer Discretionary capital spending cycles and macro interest-rate shifts (Beta 1.00x)?

BNKK Live News Feed, Press Releases & Catalyst Wire

Real-time company headlines, analyst actions, and sector developments for Bonk Inc. (BNKK) • Click "Debate This Headline" to argue it in the Roar Pit below

💬 Jump to BNKK Debate Forum (3) ↓
🔥 THE ROAR PIT • LIVE COMMUNITY DEBATE 3 Active Posts & Replies

BNKK Bull vs. Bear Conversation Board — What's Your Call at $1.06?

🐂 67% BULLISH CONVICTION COMMUNITY TUG-OF-WAR ON BNKK 🐻 33% BEARISH CONVICTION
1. Pick Your Side on BNKK:
💡 Tip: Back up your call with a price target or RQD metric to get upvoted to the top.
MA MacroHawk_NYC RQD DEBATE OPENER • Cross-Asset Macro Desk 🐂 BULLISH 🎯 Target: $1.33 (+23.1%)
📌 Pinned Debate

Revenue grew from $0.2M in FY 2023 to $2.1M in FY 2025, showing top-line expansion.

The street is overcomplicating Bonk Inc. (BNKK). Revenue grew from $0.2M in FY 2023 to $2.1M in FY 2025, showing top-line expansion.. With an RQD score of 32/100 (E) and Forensic Balance Sheet at 11/20, any positive earnings surprise or guidance raise forces underweight funds to chase above $1.17.

EarningsSniper 🐂 BULL

@MultipleCompression Shorting a 3/20 institutional whale-flow stock at $1.08 is dangerous when funds are rotating into Consumer Discretionary.

MU MultipleCompression RQD DEBATE OPENER • Valuation Discipline 🐻 BEARISH 🎯 Target: $0.81 (-25.0%)
Spot @ $1.08

Net loss widened to -$68.2M in FY 2025 with ROIC at -35% and FCF yield at 0%.

I respect the product at Bonk Inc., but the stock at $1.08 is a different story. Net loss widened to -$68.2M in FY 2025 with ROIC at -35% and FCF yield at 0%.. FCF yield is 0.0% and RQD sits at 32/100 (E) — why pay up here when you can wait for next quarter's numbers?

LIVE TAPE